Moneta Group Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

Moneta Group Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	+4,715	New	+$285K	﹤0.01%	607
2025 Q4	–	Sell	-5,164	Closed	-$429K	–	816
2025 Q3	$429K	Sell	5,164 -406	-7%	-$29.4K	﹤0.01%	536
2025 Q2	$409K	Sell	5,570 -126	-2%	-$9.13K	﹤0.01%	485
2025 Q1	$651K	Sell	5,696 -509	-8%	-$31K	0.01%	359
2024 Q4	$313K	Buy	6,205 +587	+10%	+$30.8K	﹤0.01%	521
2024 Q3	$260K	Buy	+5,618	New	+$200K	﹤0.01%	555
2018 Q2	–	Sell	-2,925	Closed	-$48K	–	436
2018 Q1	$48K	Buy	+2,925	New	+$54.2K	0.01%	326

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Moneta Group Investment Advisors's CORT Position: Q2 2026 in Review

Moneta Group Investment Advisors opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 4,715 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #607 among its holdings. This is a return to the name: Moneta Group Investment Advisors previously reported a position in CORT as recently as Q3 2025.

Moneta Group Investment Advisors first reported a position in CORT in Q1 2018 and has held it in 7 quarters since. The position peaked at $651K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Moneta Group Investment Advisors held 4,715 shares of Corcept Therapeutics worth $410K as of Q2 2026.
Corcept Therapeutics was a new Moneta Group Investment Advisors position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #607 holding.
Moneta Group Investment Advisors first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 7 quarters since.
Moneta Group Investment Advisors's Corcept Therapeutics position peaked at $651K in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.